Bordetella pertussis is a human pathogen that can infect the respiratory tract and cause the disease known as whooping cough. B. pertussis uses pertussis toxin (PT) and adenylate cyclase toxin (ACT) to kill and modulate host cells to allow the pathogen to survive and persist. B. pertussis encodes many uncharacterized transcription factors, and very little is known about their functions. RpoE is a sigma factor which, in other bacteria, responds to oxidative, heat, and other environmental stresses. RseA is a negative regulator of RpoE that sequesters the sigma factor to regulate gene expression based on conditions. In B. pertussis, deletion of the rseA gene results in high transcriptional activity of RpoE and large amounts of secretion of ACT. By comparing parental B. pertussis to an rseA gene deletion mutant (PM18), we sought to characterize the roles of RpoE in virulence and determine the regulon of genes controlled by RpoE. Despite high expression of ACT, the rseA mutant strain did not infect the murine airway as efficiently as the parental strain and PM18 was killed more readily when inside phagocytes. RNA sequencing analysis was performed and 263 genes were differentially regulated by RpoE, and surprisingly, the rseA mutant strain where RpoE activity was elevated expressed very little pertussis toxin. Western blots and proteomic analysis corroborated the inverse relationship of PT to ACT expression in the high-RpoE-activity rseA deletion strain. Our data suggest that RpoE can modulate PT and ACT expression indirectly through unidentified mechanisms in response to conditions.
to be answered in order to understand how this pathogen infects to develop more effective vaccines (5) .
B. pertussis is transmitted by respiratory droplets and once inside the host, the bacteria will adhere to the respiratory epithelia cells of the airway (6) . After attachment, the pathogen expresses multiple toxins (1) , including the pertussis toxin (PT) and adenylate cyclase toxin (ACT). While PT has long-range effects on the host, ACT is thought to act more locally. Both of these toxins are necessary for establishment of infection in murine models (7) , but it seems pertussis toxin plays an earlier role in the establishment of infection. The combo of pertussis toxin and ACT provide a one-two punch that affects neutrophil recruitment and survival of B. pertussis in the respiratory tract (7) . The overall virulence of the pathogen is linked to expression of these toxins through what is known as the Bordetella virulence gene system, which is composed of the BvgS sensor kinase and the BvgA response regulator (1) . Several in vitro conditions have been shown to induce BvgS phosphorylation of BvgA, which subsequently cause gene expression at specific genes throughout the genome. BvgAS controls expression of hundreds of genes (8) that are necessary and sufficient for virulence of Bordetella (9) in murine models of infection (10) . These genes can be classified into three phenotypic phases: Bvg Ϫ (ex vivo), Bvg i (transmission) (11) , and Bvg ϩ (in vivo) (1) .
It is apparent that Bvg-dependent genes play key roles during the infectious process; however, there are likely other transcription factors that modulate gene expression and influence B. pertussis virulence. Encoded by the reference Tohama I genome, there are at least 10 putative sigma factors in addition to the housekeeping protein RpoD (data not shown). Little is known about most of the sigma factors, except for the extracytoplasmic sigma factor RpoE ( E /SigE). In Bordetella bronchiseptica, Sig E has been shown to facilitate survival of membrane perturbations and is required for virulence in immunocompromised mice (12) . It has also been shown that in B. pertussis RpoE influences alleviation of membrane stress (13) . RpoE is controlled by an anti-sigma factor known as RseA. RseA sequesters RpoE to the inner membrane, which renders it transcriptionally inactive; however, proteolytic cleavage of RseA or genetic mutation to rseA results in transcriptional activation of RpoE. Deletion of rseA from B. pertussis strain UT25 resulted in an increased amount and diversity of periplasmic proteins (13) . Surprisingly, it was shown that the rseA gene deletion mutant (PM18) of the B. pertussis strain UT25 also released a large amount of adenylate cyclase toxin (ACT) into the culture media (13) . Not only was more ACT released but it also was of greater stability (13) . Furthermore, cell membrane stress caused by hydrogen peroxide activated increased release of ACT (13) .
In this study, we observed that in the absence of the RseA anti-sigma factor (PM18 strain), B. pertussis was less able to infect the lungs of outbred mice or survive in J774A.1 cells or neutrophils. Since RpoE is a sigma factor and could have global effects on gene and protein expression, we hypothesized that there could be alterations in the pertussis toxin expression profile of this strain. We used RNA sequencing (RNA-seq) and shotgun proteomics to identify the genes and proteins that are controlled by RpoE to expand upon what we know about B. pertussis gene expression. We observed that in the absence of the anti-sigma factor RseA, there was an inverse relationship between expression of genes encoding ACT and PT. While we observed increased ACT, decreased PT was measured both at the level of mRNA and protein. Our data indicate the RpoE system can influence expression of virulence factors and likely plays a role in pathogenesis.
RESULTS AND DISCUSSION
It was previously shown that the B. pertussis PM18 strain (UT25 with an in-frame rseA gene deletion) produced and secreted more ACT than the parental UT25 strain (13) . Based on this, we hypothesized that the PM18 strain would be highly fit in vivo and efficiently infect the airways of mice due to the roles of ACT in facilitating infection. To test this hypothesis, we infected outbred CD1 female mice with 2 ϫ 10 7 CFU of either UT25 (parental strain) or PM18 (UT25ΔrseA mutant) by intranasal infection and deter-mined the bacterial burden of the nares (by nasal wash), trachea, and lungs at 24, 48, and 144 h postchallenge. In the nasal wash, we observed statistically fewer viable PM18 organisms at 144 h postchallenge but otherwise no difference at 24 or 48 h ( Fig. 1A) . It is important to point out that a nasal wash only contains the bacteria that can be flushed out of the nares and likely does not equal the total number of viable bacteria in the nares. In the trachea, we observed no statistical differences between the bacterial burdens and any of the three time points ( Fig. 1B) . Unlike the trachea, the bacterial burdens in the lungs were strikingly different. At 24 h postchallenge, the amount of viable PM18 bacteria in the lung was statistically increased over that of UT25, which would be consistent with our hypothesis. At 48 h, there was a statistically significant increase in viable UT25 bacteria compared to PM18. These data, while puzzling to rationalize, suggest that in the absence of rseA, highly activated RpoE affected gene expression to an extent that altered virulence, even though both strains were in Bvg ϩ phase upon visual inspection on Bordet Gengou (BG) agar, both before and after the murine challenges. Based on the murine challenge data, we next wondered if PM18 was more susceptible to cellular killing by macrophages or neutrophils. To test this, J774A.1 cells were infected with UT25 or PM18 ( Fig. 1D ). At both 2 and 24 h postinfection, intracellular PM18 was more susceptible to killing by the J774A.1 cells. To expand on these data, bone marrow-derived neutrophils were isolated and infected in a manner similar to that of the J774A.1 assay. Intracellular and extracellular survival of UT25 and PM18 was determined. Statistically fewer PM18 bacteria were viable after 2 h inside the neutrophils (Fig. 1E ). However, extracellular UT25 and PM18 both survived 2 h of incubation with neutrophils. The decreased survival in mice and inside cells were the exact opposite results that would be predicted by our hypothesis. For this reason, we conducted additional analyses to identify the genes controlled by the RpoE sigma factor to understand how this transcription factor may impact the virulence of B. pertussis.
Mapping the RpoE regulon of B. pertussis with Illumina RNA-seq. In many bacteria, RpoE controls expression of factors which can ameliorate membrane stress,
Colonization of the murine airway or survival in J774A.1 and neutrophils by B. pertussis strain UT25 and the isogenic PM18 (ΔrseA) strains. CD1 mice were infected with 2 ϫ 10 7 CFU of the B. pertussis strains UT25 and PM18. At 24, 48, and 144 h postinfection, the bacterial burdens of the nasal wash (A), trachea (B), and lungs (C) were determined. Four to five mice were used for each time point, and all of the values obtained are indicated. At 144 h, the level of PM18 measured by the nasal wash (1 ml) was significantly lower than that of the parental UT25. In the lungs, PM18 was present in a larger amount at 24 h but then decreased as UT25 increased (*, P Ͻ 0.05; **, P Ͻ 0.01). J774A.1 cells were allowed to phagocytose UT25 or PM18. (D) Less viable PM18 organisms were observed at both 2 and 24 h postinfection. Bone marrow-derived neutrophils were isolated and allowed to phagocytose UT25 or PM18, and similar to J774A.1 cells, PM18 was more efficiently killed intracellularly (E) but not extracellularly (F). heat shock, and desiccation. We sought to profile the effect of RpoE on B. pertussis gene expression by comparing strain UT25 to its isogenic rseA deletion mutant, PM18, by RNA-seq. To perform RNA-seq, RNA was prepared from B. pertussis strains UT25 and PM18, growing in Stainer-Scholte liquid medium (SSM). Three pools of RNA were collected from cultures grown up to an optical density at 600 nm (OD 600 ) of 0.8. Three separate cDNA libraries were generated and each sequenced on the Illumina MiSeq platform in one lane. Each library was sequenced with ϳ27 million reads (2 by 76 bp). For standardization and clarity, the reads were mapped to the reference Tohama I genome. On average, 83% of all reads mapped to Tohama I.
RNA-seq analysis of UT25 and PM18 resulted in read data for 90.8% of the genome (3,502 B. pertussis genes). If the IS481 transposase and ribosomal genes are excluded, then only 2.4% of genes encoded were not detected. The B. pertussis Biocyc annotation indicates that 10% of Tohama I genes are pseudogenes. However, based on our RNA-seq analysis, it is possible that as many as 7% of these genes are expressed at the RNA level. ssrA encodes a regulatory RNA which tags proteins for degradation, and ssrA was the most expressed transcript in all libraries sequenced, with an average read per kilobase per million (RPKM) of 609,274 (see Table S1 in the supplemental material).
Effect of rseA deletion and subsequent RpoE activation on the transcriptome of B. pertussis. Comparing the gene expression profiles of UT25 and PM18, we identified 263 genes ( Fig. 2A and B ) that were differentially expressed between UT25 and PM18 (P Ͻ 0.05) (Table S1 ). Of this set of genes, 138 were repressed and 125 were activated ( Fig. 2A ). The predicted localizations of the products encoded by these differentially expressed genes were used to determine which cellular compartments were most affected by RpoE activation in PM18. Most activated genes correspond to the cytoplasmic membrane, whereas most repressed genes encode cytoplasmic proteins ( Fig. 2B ). For extracellular, outer membrane, periplasmic, and unknown products, equal numbers of activated and repressed genes were observed ( Fig. 2B ). To better understand the classes of genes dysregulated, hypergeometric tests on annotations (14) were performed. In this analysis, we compared the activated and repressed gene sets to the B. pertussis whole annotation to determine if annotation classes were overrepresented. Within the repressed gene set, 28 annotations out of 525 were found to be enriched. The term with the smallest P value was pathogenesis (P value of 6.5eϪ10). There are 20 genes in the B. pertussis genome that were annotated with the term pathogenesis. Within the set of 138 repressed genes, 10 are annotated as being involved in pathogenesis (Table S1 ). Of these genes, almost all genes associated with pertussis toxin were repressed ( Fig. 3A ; Table S1 ). These data suggest that RpoE repressed factors, such as pertussis toxin, that facilitate virulence. Surprisingly, 11 annotations corresponding to ATP synthesis/electron transport were statistically overrepresented in the suppressed gene set. This suggests that RpoE expression leads to a decrease in expression of genes involved in ATP synthesis in B. pertussis, thereby affecting metabolism (Fig. 3A) . The activated gene set (125 genes) had 11 annotations that were overrepresented with statistically significant P values (Ͻ0.05), and 18 genes in this set are annotated as being involved in transport. Additionally, proline catabolism and siderophore biosynthesis/ transport genes were also overrepresented ( Fig. 3B ). In the B. pertussis genome, 3 genes are annotated as being involved in biofilm formation, and within our activated gene set, 2 were observed. This suggested RpoE has a role in expression of biofilm synthesis genes.
Role of RpoE in secretion of adenylate cyclase toxin and implications for biofilm formation. The expression data and bioinformatics analysis suggested that biofilm synthesis genes were upregulated in PM18. We therefore wondered if PM18 would form a more robust biofilm than UT25. Interestingly, strain PM18 formed less biofilm than UT25, as determined by the standard crystal violet assay ( Fig. 4A ). Studies have indicated that ACT decreased the size of Bordetella biofilms (15) . When recombinant ACT was added to laboratory strain BP338, less biofilm was detected ( Fig. 4A ). Strain UT25 forms a robust biofilm compared to BP338 ( Fig. 4A ) and was also susceptible to addition of exogenous ACT. A previous study showed that ACT secretion was increased in PM18, although the gene encoding ACT, cyaA, was not upregulated (13) . In our study, Western blot analysis revealed that PM18 expressed more ACT than UT25, and a large amount was secreted into the supernatant (Fig. 4B ). These data were corroborated by measuring the cyclase activities of the UT25 and PM18 samples ( Fig.  4B ). Here, using RNA-seq, we corroborated the previous study and observed that cyaA expression was not increased in comparisons of UT25 and PM18 transcriptomes ( Fig.  4C ). Interestingly, although cyaA expression was not statistically upregulated in PM18 ( Fig. 4C ), two of the three genes that encode the type I secretion system that are responsible for secreting ACT were upregulated in PM18, with significant P values (Fig. 4C ). The increased expression of type I secretion genes could be responsible for the increased ACT secretion. Additionally, further studies would be required to define if RpoE plays a role in posttranscriptional regulation of ACT expression by increasing translation efficiency, altering small RNA binding and activity, or altering transcript stability.
rpoE expression is not autoregulated in B. pertussis. In Gram-negative pathogens, such as P. aeruginosa, expression of the rpoE gene is autoregulated and can drive expression of its own gene through a specific promoter (16) . This allows for amplification of rpoE expression. If RpoE were autoregulated in B. pertussis, deletion of rseA would result in extremely high levels of rpoE gene expression; however, rpoE expression remained stable in the absence of rseA (Table 1 ). This suggests that B. pertussis rpoE expression is not autoregulated. If the genomic organization of B. pertussis rpoE is compared to that of either Escherichia coli or Pseudomonas aeruginosa, it is apparent that the genes immediately upstream of rpoE are different (data not shown). This suggests that some genetic rearrangements due to the organism's evolution could have influenced how RpoE is regulated. Since rseA is deleted from PM18, no rseA RNA was detected, as would be expected ( Table 1 ). The mucB gene encodes a negative regulator of RseA, and in the absence of rseA, mucB expression was slightly increased (Table 1; 1.57-fold). Since it is clear rpoE is not autoregulated, an rpoE-dependent promoter must reside somewhere in the coding sequence of rpoE to drive expression of mucB. In silico promoter prediction suggests there are several promoters with strong prediction scores in the rpoE coding region (data not shown). Downstream of mucB, another negative regulator of RseA is encoded in the mucD gene. MucD (DegP) is a chaperone protease that resides in the periplasm. In E. coli, DegP has been extensively characterized and can either refold or digest aberrant proteins (17) . In P. aeruginosa, inactivation of mucD results in high rpoE sigma factor-directed transcription (18) . In general, MucD is classified as an indirect negative regulator of RpoE activity, because the main role of MucD is to control aberrant proteins that activate proteolysis of the RseA anti-sigma factor. As expected, deletion of rseA resulted in increased mucD expression ( Table 1 ). It appears there were several promoters with strong prediction scores in the mucB coding region (data not shown) which could be responsible for mucD expression. Collectively, these results suggest that B. pertussis rpoE is not autoregulated, but RpoE does drive expression of the mucB and mucD genes that encode negative regulators of RpoE.
Comparing the proteomes of UT25 and PM18. RNA-seq was useful for identifying which genes of B. pertussis are controlled, either indirectly or directly, by RpoE. In order to increase the robustness of these analyses and better understand the role of RpoE, mass spectrometry (MS) was performed on total protein lysates of the UT25 and PM18 strains. SDS-PAGE was performed and gel fractions for each strain were submitted for total mass analysis. In total, 1,658 B. pertussis proteins were detected with 63,006 total peptides. To characterize the subcellular localizations of the proteins identified, UniProt predictions were supplemented with additional manual predictions based on the most reasonable assumption of where the protein would be in the B. pertussis cell. To analyze the total proteomic data set, we set a cutoff value of proteins at a minimum of 10 peptides. Only differences in peptide numbers between UT25 and PM18 of higher than 5 peptides were considered. Using these stipulations, 186 activated proteins and 243 repressed proteins were used to compare the subcellular localizations ( Fig. 5A ). Eleven percent of the total activated subset was outer membrane localized compared to 4% in the repressed subset. These data suggest that RpoE controls remodeling of the outer membrane in B. pertussis. Also of note, extracellular proteins were enriched in the repressed subset (Fig. 5A ). In particular, the PM18 strain had decreased pertussis toxin, which is an extracellular protein and was identified in the RNA-seq as repressed in PM18.
To compare the findings of the RNA-seq and proteomics analyses, fold changes were calculated based on the normalized spectral abundance factor (NSAF) of the UT25 and PM18 data sets (Table S2 ). In order to overlay the activated genes (RNA-seq) and proteins, a minimum average RPKM value of 10 (54 of 125 statistically significant activated genes) was used as a cutoff and compared to proteins with a minimum of 10 peptides and fold change (PM18/UT25 NSAF) of 1.5 (115 of 1,658 identified proteins). For comparisons of the repressed genes to proteins, a minimum average RPKM value of 10 (137 of 138 statistically significant activated genes) was used as a cutoff and compared to proteins with a minimum of 10 peptides and a fold change (PM18/UT25 NSAF) of Ϫ1.5 (185 of 1,658 identified proteins). Based on these cutoff values, 7.1% and 8.4% of the RNA-seq and proteomics data, respectively, correlated between the data sets ( Fig. 5B) . These correlations suggest that RpoE drives direct expression and also influences expression indirectly. The NSAF value of each protein was used to calculate a fold change between PM18 and UT25. These data were then plotted based on the corresponding gene start site of the B. pertussis chromosome (Fig. 5C ). Proteins with expression values that correlated to the RNA-seq data set are highlighted in black. In both the RNA-seq and proteomic analysis, the BP2497 putative zinc protease was highly expressed in PM18 ( Table 2 ). In terms of peptides identified in PM18, BP2497 was the third most abundant protein detected, after GroEL and EF-Tu. Due to the high expres- sion in PM18, it is possible that BP2497 expression is directly controlled by RpoE; alternatively, it is possible that an unknown intermediate transcription factor is activating BP2497 expression. BP2497 is a part of the M16 peptidase family (MEROPS accession number MER001222), which consists of mostly uncharacterized proteases. At this stage, based on our data, we cannot propose a function for BP2497; however, due to the increased release of ACT in PM18, we speculate that BP2497 could have a role in this process. Current efforts are under way to investigate this possible role. In a recent study, BP2497 was identified as a potential vaccine candidate because it was increased in both mRNA and protein expression under low-sulfate conditions, suggesting that it is Bvg regulated (19) . Using locked phase mutants, BP2497 has also been shown to be Bvg regulated (20) . In the PM18 strain, most Bvg-regulated genes/proteins were decreased in expression, yet BP2497 was highly expressed. Sulfate can decrease Bvg expression, and here we observed sulfate-binding protein (Sbp) was more highly expressed in UT25 than PM18. These results suggest that Sbp could alter intracellular sulfate and Bvg status; however, the BvgA regulator protein expression increased in PM18. These seemingly confounding data indicate that molecular underpinnings of RpoE modulation of virulence factors in B. pertussis are independent of Bvg regulation, therefore increasing the virulence versatility of the pathogen.
The colonization defects observed with PM18 in the CD1 murine infection studies lead us to hypothesize that PM18 would have decreased virulence factor expression; however, there are several factors that were expressed more highly in PM18 than UT25 ( Table 2 ). In regard to ACT and pertussis toxin, the proteomic analysis corroborated the RNA-seq analysis. When all of the pertussis toxin and secretion system proteins were counted, PM18 had substantially fewer pertussis toxin protein components. qRT-PCR and Western blot analyses corroborate RNA-seq and proteomics of PM18 and UT25. In order to support the RNA-seq and proteomic findings, mRNA expression levels were profiled for cyaA, ptxA, BP2497, mucD, bvgA, and fhaB in UT25 and PM18 at an OD 600 of 0.4 and 0.8 (Fig. 6A) . At an OD 600 of 0.4, cyaA expression was repressed in PM18 but increased at an OD 600 of 0.8. In accordance with the RNA-seq and proteomics analyses, ptxA was 20-fold lower in PM18 at an OD 600 of 0.4 (Fig. 6A) . Both BP2497 and mucD mRNA expression correlated with RNA-seq and proteomics. To confirm the proteomics, PtxA expression was determined by Western blotting in UT25 and PM18 from both pellet and supernatant, supernatant-only, and pellet-only protein lysates (Fig. 6B ). As observed with the quantitative reverse transcription-PCR (qRT-PCR) data, pertussis toxin expression was decreased in strain PM18 in total, supernatant, and pelleted cells (Fig. 6B) .
Summary and conclusion. In this study, we used a murine challenge model to determine if the sigma factor RpoE was involved in regulating the virulence of B. pertussis. To our surprise, we observed that the PM18 strain with high RpoE activity and large amounts of ACT had impaired survival in the CD1 mouse and in vitro against J774A.1 macrophages and neutrophils (Fig. 1) . We next used transcriptomics and proteomics to characterize the genes and proteins controlled by RpoE. While it is clear that BvgAS controls many key toxins and virulence factors, our understanding of B. pertussis virulence is lacking due to the fact that in the past vaccines were highly effective at preventing infections. RNA-seq, proteomics, qRT-PCR, and Western blot analyses confirmed that the PM18 strain expressed significantly less pertussis toxin than the parental strain yet expressed more ACT protein (Fig. 4A, 5C, and 6A and B ). In addition, strain PM18 also was less able to form in vitro biofilms (Fig. 4) . It is possible that the decreased pertussis toxin production and lowered ability to form biofilms contributed to the decreased bacterial survival of PM18 in the CD1 mouse. Overall, these data suggest that RpoE can both affect a wide array of genes and cause differential expression of the B. pertussis toxins.
Our data present an idea that contradicts the current dogma that pertussis toxin and ACT are controlled primarily by the Bvg system. We observed that cyaA gene expression was not significantly increased in PM18 (Fig. 4C) . However, increased levels of ACT protein can be detected (Fig. 4B) . How or why is more ACT translated and secreted in the rseA mutant? Bibova et al. showed that in the absence of the RNA chaperone Hfq, less ACT was produced, suggesting that a small RNA posttranscriptionally controls ACT translation (21) . However, we did not observe differential expression of hfq in our RNA-seq analysis (Table S1 ). In the same study, it was observed that loss of hfq resulted in decreased pertussis toxin gene and protein expression (21) . Due to these observations, it does not seem likely that hfq is responsible for the inverted pertussis-toxinto-ACT expression that we observe in the PM18 strain. Our expression data suggest that the increase in ACT is posttranscriptional, and additional studies are required to determine if this increase is associated with changes in posttranslational regulation. We next observed a slight decrease in bvgA expression (P value of 0.04) that could account for decreased pertussis toxin gene expression. However, we do not understand how an increase in RpoE could lead to a decrease in bvgA. We now hypothesize that local stress conditions, such as oxidative stress, lead to RseA degradation, resulting in ACT release. Another logical next step would be to directly determine the target promoters that RpoE binds. It is clear to us that more work needs to be done to understand the transcriptional and metabolic networks of B. pertussis.
If RseA acts upon RpoE as it does in other Gram-negative organisms, then loss of RseA should significantly increase RpoE activity. This high RpoE activity would not likely be a constitutive physiological condition. Normally, RseA inhibition of RpoE in the wild-type situation would be dynamic, and when conditions warranted, RseA would impose its inhibition, thereby decreasing RpoE activity. Such regulation allows for efficient yet dynamic modulation of factors needed during stress conditions. In the case of P. aeruginosa, the enzymatic machinery to synthesize and secrete the exopolysaccharide alginate is controlled by the RpoE ortholog AlgU(T) (22) . Under conditions where alginate is needed for protection, the MucA anti-sigma factor is proteolytically cleaved to release AlgU (23) . We hypothesize that stress conditions induce the proteolytic cleavage of B. pertussis RseA. In Fig. 7 , a schematic of the putative regulators of RpoE in B. pertussis is shown. RseA is the main negative regulator of RpoE, and its function, based on other characterized systems, would be to sequester RpoE to the inner membrane, preventing its association with RNA polymerase. To activate RpoE, MucB is released from RseA by some yet-unknown mechanism, and the AlgW (DegS) protease would then cleave RseA to activate the proteolytic process. Subsequent RseA cleavage by the inner membrane protease, MucP, and the cytoplasmic ClpXP would then result in an uninhibited RpoE that would drive expression of its target genes. Hanawa et al. demonstrated that hydrogen peroxide can induce RpoE activity in B. pertussis (13) , which suggests that RseA inhibition can be removed, likely by proteolytic cleavage; however, direct experiments will be necessary to establish this mechanism. It is possible that during the infectious process, B. pertussis encounters stress conditions that induce RpoE activity. Based on this, it is likely that proteins expressed by RpoE are expressed at key steps during infection, and therefore these may turn out to be useful vaccine antigens. In this study, we have used transcriptomics, proteomics, and validation experiments to establish a regulon of genes and proteins under the control of RpoE. Future studies will be focused on dissecting the regulatory networks of B. pertussis in the context of RpoE and other transcription factors so that a more complete landscape of how B. pertussis is able to infect can be determined.
MATERIALS AND METHODS
Bacterial strains and growth conditions for murine challenge. B. pertussis strains BP338 (wild type; Tohama I), UT25 (UT25Sm1) (24) , and PM18 (UT25Sm1ΔrseA) (13) were cultured on Bordet Gengou (BG) agar (25) (Remel) supplemented with 15% defibrinated sheep blood (Cocalico Biologicals) for 48 h at 36°C. Bacteria were transferred from BG plates to three flasks of 12 ml of modified Stainer-Scholte liquid medium (SSM) (26) . SSM cultures were not supplemented with cyclodextrin unless indicated. SSM cultures were grown for ϳ22 h at 36°C with shaking at 180 rpm until the OD 600 reached 0.8. The cultures were then diluted to provide a challenge dose of 2 ϫ 10 7 CFU in 20 l. Four-week-old CD1 mice were obtained from Charles River. Mice were anesthetized by intraperitoneal injection of ketamine and xylazine in saline. Two 10-l doses of the B. pertussis strain were pipetted directly into each nostril of the mouse. Five to seven mice were infected with strain UT25 or PM18, and at 24, 48, and 144 h postchallenge, mice were euthanized for determination of bacterial burden in the nasal wash, trachea, and lungs. To determine the number of B. pertussis organisms in the nares, 1 ml of phosphate-buffered saline (PBS) was flushed through the nares and collected. Trachea and lungs were extracted and homogenized. Serial dilutions in PBS were plated on BG containing streptomycin (100 g/ml) to ensure only B. pertussis strain UT25 or PM18 was cultured. All murine infection experiments were performed according to protocols approved by the University of Virginia Animal Care and Use Committee (protocol number 4004), conforming to AAALAC international accreditation guidelines.
J774A.1 macrophage intracellular killing assay. J774A.1 macrophages (ATCC) were cultured at 37°C in 5% CO 2 in Dulbecco's modified Eagle medium (DMEM) containing 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin. J774A4.1 cells were counted with a hemocytometer and diluted, and 10 6 cells were added to a 24-well tissue culture plate and incubated for 2 h. After incubation, DMEM was removed and wells washed 3 times with PBS. B. pertussis strains were grown as described above and diluted to 10 8 CFU/ml. Cells were infected with either UT25 or PM18 at a multiplicity of infection (MOI) of 50. Dose of infection was quantified by plating of serial dilutions on BG plates. To facilitate bacterial interaction with J774A.1, cell tissue culture plates were centrifuged at 550 ϫ g for 5 min and then incubated for 1 h at 37°C in 5% CO 2 . Nonadherent bacteria were removed with medium and wells were washed 3 times with PBS. DMEM with 100 g/ml polymyxin B sulfate (TOKU-E) was added to each well to kill extracellular bacteria, and wells were incubated for 1 h. After incubation, antibiotic concentration was reduced to 5 g/ml to stop bacterial replication. Intracellular viable bacterial levels were determined at 2 and 24 h postinfection. At each time point, cells were washed 3 times with PBS and then lysed by 5 min of incubation in sterile water. Wells were scraped and serial dilutions of lysates were plated on BG plates to determine CFU counts. Student's t tests at a 95% confidence level were used to analyze 3 biological replicates of each experimental condition.
Bone marrow-derived neutrophil (BMDN) isolation. Bone marrow was isolated from femurs and tibias of 2 wild-type 129S2/SvHsd (Envigo) mice. Bone marrow was flushed using 15 ml of DMEM. Cell solution was centrifuged at 1,000 ϫ g for 5 min and then resuspended in 5 ml of DMEM. Neutrophils from cell suspensions were isolated by addition of 5 ml of lympholyte-M (Cedarlane) to the cell suspension and then centrifuged at room temperature for 20 min at 1,200 ϫ g. The gradient layer corresponding to the neutrophils was resuspended in red blood cell (RBC) lysis buffer (BD Pharm Lyse; BD Biosciences), incubated for 2 min at 37°C to lyse the red blood cells, and then centrifuged at 200 ϫ g for 5 min. Supernatant was removed and neutrophils resuspended in DMEM before counting by a hemocytometer. The neutrophil population was visually inspected after Kwik diff staining (Thermo Fisher) and light microscopy.
BMDN intracellular and extracellular killing assay. Neutrophil cellular killing assays were performed similarly to the macrophage assays described above. Neutrophil suspensions were diluted and 10 6 cells were added to 1.5-ml tubes. Cells were centrifuged at 1,000 ϫ g for 5 min and supernatant was removed. B. pertussis strains were grown as described above and diluted to 10 7 CFU/ml for the extracellular killing assay and 10 8 CFU/ml for the intracellular killing assay. Cells were infected at an MOI of 200 and then incubated at 37°C in 5% CO 2 for 1 h for the neutrophil uptake assay and 2 h for the extracellular killing assay. After incubation, the cell suspensions were centrifuged under experimental conditions. At this point the supernatants from the cell suspensions used for the extracellular killing assay were serially diluted and plated on BG plates. Cell suspensions used for the neutrophil uptake assay were washed once with PBS. DMEM with 100 g/ml polymyxin B sulfate (TOKU-E) then was added to each well to kill extracellular bacteria and incubated for 1 h. After incubation, cells were centrifuged and lysed with sterile water, and then lysate serial dilutions were plated on BG plates as previously described in the macrophage assay. Student's t tests at a 95% confidence level were used to analyze 3 biological replicates of each experimental condition.
Growth conditions for RNA and protein sample preparation for RNA-seq and proteomics. B. pertussis strains UT25 and PM18 were cultured on BG agar at 36°C for 48 h. B. pertussis cells were collected from the plate using a swab and transferred to three flasks of 12 ml of modified SSM (26) . SSM cultures were grown for ϳ22 h at 36°C with shaking at 180 rpm, at which time the OD 600 was 0.8. The SSM cultures were then transferred to 200 ml of SSM and the OD 600 matched to 0.1. After 22 h at 36°C with shaking at 180 rpm, the OD 600 of each culture was 0.8. One milliliter of cells from each culture was pelleted (20,000 ϫ g, 1 min) and resuspended in RNAprotect bacterial reagent (Qiagen) to stabilize the RNA in the cells. The suspension was then pelleted (20,000 ϫ g, 1 min) and 900 l of RNAprotect supernatants was removed by pipetting. The RNAprotect cell samples were then stored at Ϫ80°C until RNA was isolated. The remaining ϳ200 ml of SSM culture was pelleted by centrifugation (12,000 ϫ g; 4°C; 1 h).
Isolation of RNA, library construction, and Illumina sequencing. RNA was isolated using an RNeasy minikit (Qiagen) as specified by the instructions of the manufacturer. The resulting RNA was pooled from the three technical samples for each strain and treated with RNase-free DNase (Qiagen). To remove the DNase, the samples were then cleaned up on another RNeasy Mini column. The resulting RNA was quantified on a NanoDrop ND-1000 (NanoDrop). RNA integrity next was assessed by running the samples on an Agilent BioAnalyzer RNA Pico chip. All samples were observed to have RNA integrity scores of 10 and then were submitted to two rounds of Ribo-Zero rRNA depletion (Illumina) and reassessed for RNA integrity. rRNA-depleted mRNA samples were then fragmented and prepared in libraries that were sequenced on an Illumina MiSeq by the University of Virginia Department of Biology Genomics Core. One biological sample of UT25 and PM18 each were sequenced on one Miseq lane, thus using three lanes in total for 81 million 2-by 76-bp reads.
RNA-seq and bioinformatics analyses. The reads were aligned to the B. pertussis Tohama I genome (27) using CLC Genomics Workbench version 8. Reads per kilobase per million (RPKM) and fold change for each gene were calculated. Empirical analysis of digital gene expression (EDGE) was performed to determine differentially expressed genes (28) . Genes with an EDGE test P value of Ͻ0.05 were considered differentially regulated. Gene set enrichment (GSEA) (14) , hypergeometric tests on annotations (29) , and STRING database analysis (30) were performed to determine the systems of related genes and pathways that were differentially expressed. Subcellular localization for the B. pertussis reference strain Tohama I gene products was obtained from pSORTb V 3.0 (31) .
RNA isolation and qRT-PCR. B. pertussis strains UT25 and PM18 were cultured under the same conditions as those described above for RNA-seq analysis. Briefly, cells were stored at Ϫ80°C in RNAprotect (Qiagen), cells were lysed with lysozyme, and RNA was isolated with RNeasy minikits (Qiagen). DNA was digested using off-column digestion with RNase-free DNase and reisolated with another RNeasy column. RNA concentration and quality were assessed on a Molecular Devices i3 SpectraMax Spectra drop plate. To ensure RNA was DNA free, 25 ng of RNA was checked by PCR amplification and was only used for cDNA if no amplicon was observed and a threshold cycle (C T ) of Ͼ32 was acheived. cDNA was synthesized using Moloney murine leukemia virus (MMLV) reverse transcriptase (Promega) per the manufacturer's instructions using 250 ng of RNA and gene-specific reverse primers for targets. Twenty-five-microliter qPCR mixtures were set up with SYBR green PCR master mix (Applied Biosystems) per the manufacturer's instructions using 1 l of cDNA. A minimum of three technical replicate reactions were run per gene target per sample on a StepOnePlus qPCR thermocycler (Applied Biosystems). Primers were designed on Primer3 (Primer-Blast; NCBI) and checked for specificity by PCR. Melt curve analysis as well as subsequent agarose gel electrophoresis were performed on all reactions. Gene expression was normalized to the rpoB reference using the 2 ϪΔΔCT method (32) . For statistical analysis, the ΔC T for the three biological replicate experiments was calculated and Student's t test was performed in Microsoft Excel 2013. Standard errors of the means was calculated based on the interval of the ΔC T of the three biological replicates. The following primer sequences used in this study were described in a study by Bibova et al. (21) : cyaF (CGAGGCGGTCAAGGTGAT), cyaR (GCGGAAGTTGGACAG ATGC), ptxAF (CCAGAACGGATTCACGGC), ptxAR (CTGCTGCTGGTGGAGACGA), bvgAF (AGGTCATCAATGC CGCCA), bvgAR (GCAGGACGGTCAGTTCGC), fhaBF (CAAGGGCGGCAAGGTGA), fhaBR (ACAGGATGGCGAA CAGGCT), rpoBF (GCTGGGACCCGAGGAAAT), and rpoBR (CGCCAATGTAGACGATGCC). The following primers for BP2497 were designed for this study: BP2497F (TCGGATCGCACCAATTACTTC) and BP2497R (CCTTGGCGATCAGCGAGTT).
Western blot analysis. B. pertussis strains were grown on BG for 48 h and then transferred to SSM and grown at 36°C until reaching an OD 600 of 0.4 for pertussis toxin or 0.8 for ACT blots. A minimum of four biological replicates were grown for each strain. Total culture samples were directly taken from the culture. A replicate set of total cultures was pelleted at 6,000 ϫ g for 3 min at 4°C. Fifteen microliters of total culture, pellets, and supernatant samples were mixed with 15 l Laemmli buffer (33) and boiled for 5 min. Samples were then cooled on ice and loaded onto 12% polyacrylamide gels for electrophoresis (Mini-PROTEAN II cell; Bio-Rad). Gels were then electroblotted onto polyvinylidene difluoride (PVDF) membranes (Micro Separations). To ensure proper loading and transfer, Memcode (Pierce) was used to reversibly stain the PVDF membranes. The membrane was blocked with 5% nonfat dry skim milk in Tris-buffered saline (TBS)-Tween (0.01%). The primary antibodies were diluted 1:2,000 in blocking buffer. The membrane was probed for 2 h with either mouse monoclonal anti-pertussis toxin (clone number qRT-PCR analysis and analyzed data; C.H. performed biofilm assays and analyzed data; M.G. performed cyclase assays and ACT Western blotting; E.H. designed experiments and composed the manuscript; F.H.D. designed/performed experiments (murine infection model, RNA-seq, proteomics, etc.), analyzed data, and composed the manuscript. We thank the reviewers of the manuscript for their comments and suggestions.
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